MarketRippa logo MarketRippa

16 January 2026 - Top Stories

Coverage across health, digital health, funding, and policy developments in Australia.

Daily digest

13 articles

Methodology: This digest condenses the source coverage listed below for faster scanning by Australian health teams. It is not medical advice.

Australian health and health‑tech news today covers policy shifts, care delivery choices and major population health programs that will shape executive priorities this year. Notable developments include the nationwide push on cancer screening, a DNA screening proposal, and how AI and data governance will influence clinical workflows and patient access.

In screening, the national lung cancer program has continued to gain momentum, with enrolment approaching 50,000 since its July 2025 start. Separately, Monash University researchers are advocating for a publicly funded DNA screening program, based on a pilot that enrolled 10,000 adults aged 18–40 and tested for 10 actionable genes, with high‑risk variants identified in participants.

On funding and payments, reform of Medicare rebates is moving toward an electronic funds transfer system. Gap‑only billing will be limited to services with rebates above $697, affecting thousands of providers and patients but accounting for less than 1% of total Medicare spending. The change is expected to influence pricing strategy and upfront patient costs for general practices.

In service delivery, the Northern Territory has seen significant disruption in maternity care as Darwin Private Hospital closes its maternity services, leaving no private obstetricians in the region. Public hospitals will absorb roughly 350–400 additional deliveries each year, underscoring the need for better public–private coordination and planning nationwide.

Public health and clinical guidance also featured updates. ATAGI adjusted measles vaccination guidance for infants travelling overseas, requiring a repeat dose for 6–11 month recipients and a follow‑up schedule to complete by 18 months. The AMA issued a careful stance on complementary and alternative medicines, emphasising evidence‑based use, potential interactions and the need for clinician decision support and accurate patient information.

Looking ahead, AI is shifting how health data is accessed and used. While policy frameworks evolve, experts warn that policy may lag behind rapid AI advances, making interoperable, high‑quality data and patient‑centric data flows essential. Separately, platform‑level decisions for Australian EMR/EHR systems are emphasised, with boards seeking cross‑organisation data sharing and stronger cyber resilience.

  • Prepare for EFT‑based Medicare rebates; gap billing will be limited to services above $697, impacting pricing and cashflow for GPs.